[1]李辰,乔淑琴△.视网膜激光光凝联合复方血栓通治疗非增殖期糖尿病视网膜病变58例[J].西部中医药,2017,30(10):90-92.
　LI Chen,QIAO Shuqin.Panretinal Photocoagulation Combined with Compound XueShuanTong Capsules in Treating 58 Cases of Non Proliferative Diabetic Retinopathy[J].Western Journal of Traditional Chinese Medicine,2017,30(10):90-92.
点击复制

视网膜激光光凝联合复方血栓通治疗非增殖期糖尿病视网膜病变58例()
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
30
期数:
2017年10期
页码:
90-92
栏目:
出版日期:
2017-10-15

文章信息/Info

Title:
Panretinal Photocoagulation Combined with Compound XueShuanTong Capsules in Treating 58 Cases of Non Proliferative Diabetic Retinopathy
文章编号:
1004-6852(2017)10-0090-03
作者:
李辰，乔淑琴△
兰州市第一人民医院眼科，甘肃 兰州 730050
Author(s):
LI Chen, QIAO Shuqin△
Department of Ophthalmology, The First People’s Hospital of Lanzhou City, Lanzhou 730050, China
关键词:
糖尿病视网膜病变; 复方血栓通胶囊; 全视网膜激光光凝
Keywords:
diabetic retinopathy;  compound XueShuanTong capsules;  PRP
分类号:
R587.2
文献标志码:
B
摘要:
目的：观察全视网膜激光光凝（PRP）联合复方血栓通胶囊治疗非增殖期糖尿病视网膜病变的临床疗效。方法：将116例（116眼）患者随机分为2组。对照组58例单纯给予PRP治疗,观察组58例给予PRP联合复方血栓通胶囊口服治疗。观察2组治疗前后视网膜厚度的变化情况及临床疗效和视力变化情况。结果：总有效率观察组为84.48%，对照组为62.07%，2组比较差异有统计学意义(P＜0.05)。视力总有效率观察组为82.76%，对照组为56.90%，2组比较差异有统计学意义(P＜0.05)。视网膜厚度治疗前后2组组内比较，差异有统计学意义(P＜0.05)；治疗后各时间点组间比较，差异有统计学意义(P＜0.05)。结论：口服复方血栓通胶囊联合PRP可提高非增殖期糖尿病视网膜病变治疗效果。
Abstract:
Objective: To observe clinical effects of panretinal photocoagulation(PRP) combined with compound XueShuanTong capsules in the treatment of non proliferative diabetic retinopathy(NPDR). Methods: All 116 patients (116 eyes) were randomized into two groups. 58 cases of the control group were treated by PRP only, while 58 cases of the observation group accepted PRP and oral administration of compound XueShuanTong capsules. The vision changes, clinical effects and retinal thickness of both groups were observed before and after treating. Results: Total effective rate of the observation group was 84.48%, higher than 62.07% of the control group, and the difference had statistical meaning(P＜0.05). Total visual acuity of the observation group was 82.76%, higher than 56.90% of the control group, and the difference showed statistical meaning(P＜0.05). The difference showed statistical meaning in the comparisons of retinal thickness before and after treating within the groups(P＜0.05); the difference indicated statistical meaning in the comparisons between both groups after treating at different times (P＜0.05). Conclusion: Oral administration of compound XueShuanTong capsules combined with PRP could improve therapeutic effects of NPDR.

相似文献/References:

[1]张喜芬,赵保礼,杨立波,等.通络明目胶囊治疗糖尿病视网膜病变的随机双盲对照研究[J].西部中医药,2013,26(11):88.
　ZHANG Xifen,ZHAO Baoli,YANG Libo,et al.A Randomized, Double-blind and Placebo-controlled Study of TongLuo MingMu Capsule in Treating Diabetic Retinopathy[J].Western Journal of Traditional Chinese Medicine,2013,26(10):88.
[2]罗向霞,张定华,史晓伟,等.糖网康对非增殖期糖尿病视网膜功能保护作用的实验研究*[J].西部中医药,2014,27(08):11.
　LUO Xiangxia,ZHANG Dinghua,SHI Xiaowei,et al.Experimental Study on TangWangKang Protecting Retinal Function of the Patients with Diabetes Mellitus at Non-proliferation Phase[J].Western Journal of Traditional Chinese Medicine,2014,27(10):11.
[3]段俊国,罗向霞△,许国旺,等.DR病情进展与阳虚病机关系的研究[J].西部中医药,2013,26(08):1.
　DUAN Junguo,LUO Xiangxia,XU Guowang,et al.Study on the Relationship between the Progression and Yang-deficiency Mechanism of Diabetic Retinopathy[J].Western Journal of Traditional Chinese Medicine,2013,26(10):1.
[4]陈雁君,刘求红,刘红.基于网络药理学的复方血栓通胶囊治疗视网膜静脉阻塞机制研究[J].西部中医药,2024,37(01):88.[doi:10.12174/j.issn.2096-9600.2024.01.18]
　CHEN Yanjun,LIU Qiuhong,LIU Hong.The Mechanism of Compound Xueshuantong Capsules in the Treatment of Retinal Vein Occlusion Based on Network Pharmacology[J].Western Journal of Traditional Chinese Medicine,2024,37(10):88.[doi:10.12174/j.issn.2096-9600.2024.01.18]

备注/Memo

备注/Memo:
收稿日期：2017-05-29 作者简介：李辰(1972—)，男，副主任医师。研究方向：眼科疾病的诊治。 △通讯作者：乔淑琴(1976—)，女，硕士学位，副主任医师。研究方向：眼科疾病的诊治。
更新日期/Last Update: 2017-10-15